Poly(ethylene glycol)-modified proteins: implications for poly(lactide-co-glycolide)-based microsphere delivery. [electronic resource]
Producer: 20090723Description: 88-98 p. digitalISSN:- 1550-7416
- Adsorption
- Delayed-Action Preparations
- Drug Carriers
- Drug Compounding
- Drug Stability
- Gels
- Half-Life
- Human Growth Hormone -- administration & dosage
- Humans
- Injections, Subcutaneous
- Lactic Acid -- pharmacokinetics
- Microspheres
- Muramidase -- administration & dosage
- Peptides -- administration & dosage
- Polyethylene Glycols -- pharmacokinetics
- Polyglycolic Acid -- pharmacokinetics
- Polylactic Acid-Polyglycolic Acid Copolymer
- Protein Stability
- Proteins -- administration & dosage
- Silicon Dioxide
- Solvents -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.; Review
There are no comments on this title.
Log in to your account to post a comment.